Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult Subjects

Clinical trial NCT02876796 · COMPLETED

Trial details

NCT number: NCT02876796
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

PD Effects of GS-0976 (NDI-010976) on Fractional DNL

Start date: 2015-08-01
Primary completion: 2015-09-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.